| Department of Medicine

DOM In the News

Read about how the Department of Medicine is responding to the outbreak of the coronavirus respiratory illness COVID-19. See related COVID-19 publications.

Nailing the nuance on COVID-19.

Patient-reported outcomes with selpercatinib treatment in patients with RET-driven cancers in the phase I/II LIBRETTO-001 trial.

Feasibility and benefits of exercise training in patients on maintenance dialysis.

Functional properties of a synthetic chicken parathyroid hormone-related protein 1-36 fragment.

Anne Rosenthal, MD

Treatment and Outcomes of Oropharyngeal Cancer in Patients with Human Immunodeficiency Virus.

Experience of Community Neurologists Providing Care for Patients With Neurodegenerative Illness During the COVID-19 Pandemic.

In vitro efficiency of 9-(N-cinnamoylbutyl)aminoacridines against blood- and liver-stage malaria parasites.

High mammographic breast density is independent predictor of local but not distant recurrence after lumpectomy and radiotherapy for invasive breast cancer.

HIV-Related Medical Admissions to a South African District Hospital Remain Frequent Despite Effective Antiretroviral Therapy Scale-Up.

Surrogate decision-makers from historically marginalized populations have lower levels of preparedness for care planning.

Biomarkers of inflammation, coagulation and fibrinolysis predict mortality in acute lung injury.

CANCELED - VA Medicine Grand Rounds - Dr. Alex Monto

4/07: Dr. Alex Monto, SFVA Gastroenterology, Title TBD

Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons.

Reprogramming of human pancreatic exocrine cells to ß-like cells.